| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1986 |
| 1 | INFLIXIMAB | 1768 |
| 2 | NATALIZUMAB | 994 |
| 3 | PREDNISONE | 717 |
| 4 | INFLIXIMAB-DYYB | 683 |
| 5 | METHOTREXATE SODIUM | 586 |
| 6 | METHOTREXATE | 540 |
| 7 | ADALIMUMAB-AATY | 436 |
| 8 | ADALIMUMAB-ADAZ | 432 |
| 9 | ADALIMUMAB-FKJP | 424 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 683 | 0.1982 |
| 1 | AVALGLUCOSIDASE ALFA-NGPT | 150 | 0.1503 |
| 2 | TRIAMCINOLONE HEXACETONIDE | 15 | 0.0573 |
| 3 | ALGLUCOSIDASE ALFA | 89 | 0.0365 |
| 4 | AGALSIDASE BETA | 218 | 0.0233 |
| 5 | CALASPARGASE PEGOL | 12 | 0.0149 |
| 6 | ACEBUTOLOL HYDROCHLORIDE | 19 | 0.0148 |
| 7 | MESALAMINE | 317 | 0.0112 |
| 8 | GOLIMUMAB | 127 | 0.0101 |
| 9 | HYDROCORTISONE SODIUM SUCCINATE | 37 | 0.0093 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 2745 |
| 1 | Integrin Receptor Antagonist [EPC] | 1278 |
| 2 | Corticosteroid [EPC] | 1140 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 539 |
| 4 | Aminosalicylate [EPC] | 396 |
| 5 | Purine Antimetabolite [EPC] | 385 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 369 |
| 7 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 239 |
| 8 | Provitamin D2 Compound [EPC] | 224 |
| 9 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 220 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 239 | 0.0698 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 220 | 0.0226 |
| 2 | Integrin Receptor Antagonist [EPC] | 1278 | 0.0147 |
| 3 | Uric Acid-specific Enzyme [EPC] | 34 | 0.0088 |
| 4 | Leptin Analog [EPC] | 11 | 0.0087 |
| 5 | Provitamin D2 Compound [EPC] | 224 | 0.0075 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 91 | 0.0054 |
| 7 | Aminosalicylate [EPC] | 396 | 0.0039 |
| 8 | Purine Antimetabolite [EPC] | 385 | 0.0039 |
| 9 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 47 | 0.0035 |